Oral DMTs in Multiple Sclerosis US & EU Spotlight (multiple reports)

Oral DMTs in Multiple Sclerosis US & EU Spotlight

Real time dynamix

View complimentary data from our quarterly tracker of the US MS market, RealTime Dynamix: Multiple Sclerosis US, as well as our bi-annual tracker of the EU MS market, RealTime Dynamix: Multiple Sclerosis EU, to find out how the brands in the oral DMT class and how perceptions, attitudes, and self-reported prescribing behaviors differ between the two regions.

Contact [email protected] for more information about the highlighted report or to see if your company already has access to the report series.

All company, brand or product names and logos in this document are trademarks of their respective holders.

2018-06-18T17:14:08+00:00